TTD | Drug: D04KDB

Drug General Information
Drug ID	D04KDB
Former ID	DNC004499
Drug Name	6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526726]
Formula	C12H11N3O
Canonical SMILES	C1CC(=O)NC2=C1C=C(C=C2)N3C=CN=C3
InChI	1S/C12H11N3O/c16-12-4-1-9-7-10(2-3-11(9)14-12)15-6-5-13-8-15/h2-3,5-8H,1,4H2,(H,14,16)
InChIKey	BDMKPUAZENLRDY-UHFFFAOYSA-N
PubChem Compound ID	13885278
Target and Pathway
Target(s)	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Target Info	Inhibitor	[526726]
KEGG Pathway	Purine metabolism
	cGMP-PKG signaling pathway
	cAMP signaling pathway
	Morphine addiction
Reactome	cGMP effects
Reactome	G alpha (s) signalling events
WikiPathways	miR-targeted genes in muscle cell - TarBase
WikiPathways	miR-targeted genes in lymphocytes - TarBase
References
Ref 526726	J Med Chem. 1992 Feb 21;35(4):620-8.3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Ref 526726	J Med Chem. 1992 Feb 21;35(4):620-8.3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.

Drug Information